Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Acute Respiratory Distress Syndrome
24%
Arterial Embolization
14%
Artificial Respiration
36%
Asthma
23%
Atypical Mycobacterium
23%
Biopsy Technique
15%
Body Mass Index
19%
Bronchial Artery
16%
Bronchoscopy
14%
Chronic Obstructive Pulmonary Disease
21%
Clinical Feature
32%
Computer Assisted Tomography
71%
Dyspnea
19%
Elderly Patient
19%
Epidermal Growth Factor Receptor
18%
Forced Expiratory Volume
15%
Hazard Ratio
50%
Hospital Mortality
14%
Idiopathic Interstitial Pneumonia
28%
Idiopathic Pulmonary Fibrosis
13%
Influenza A (H1N1)
18%
Levofloxacin
18%
Low Drug Dose
14%
Lung
73%
Lung Adenocarcinoma
33%
Lung Biopsy
17%
Lung Cancer
49%
Lung Lesion
13%
Lung Nodule
20%
Lung Tuberculosis
100%
Lymphocyte
13%
Medical Record
16%
Multidrug Resistant Tuberculosis
18%
Non Small Cell Lung Cancer
49%
Odds Ratio
42%
Pathogen
13%
Patient Referral
17%
Polyethylene Terephthalate
14%
Primary Tumor
20%
Prognostic Factor
74%
Proportional Hazards Model
13%
Pulmonary Embolism
20%
Retrospective Cohort Study
21%
Sputum
18%
Sputum Culture
13%
Stenosis
24%
Stenting
20%
Thorax Radiography
17%
Transthoracic Biopsy
14%
Tuberculosis Treatment
18%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Respiratory Failure
33%
Adult Respiratory Distress Syndrome
9%
Allergic Reaction
9%
Asthma
33%
Atelectasis
9%
Atypical Mycobacterium
12%
Chest Infection
9%
Chronic Obstructive Lung Disease
30%
Cidofovir
9%
Clinical Feature
33%
Cohort Study
10%
Community Acquired Pneumonia
18%
Coughing
12%
CYP2E1
9%
Cytokine
9%
Epidermal Growth Factor Receptor
21%
Epidermal Growth Factor Receptor Kinase Inhibitor
19%
Erlotinib
25%
Femur Fracture
9%
Fibrosing Alveolitis
9%
Gefitinib
25%
Hemoptysis
17%
Hepatotoxicity
9%
Hospital Mortality
14%
Influenza A (H1N1)
10%
Influenza A Virus (H1N1)
9%
Interleukin 2
14%
Levofloxacin
18%
Loeffler Pneumonia
9%
Lung Adenocarcinoma
28%
Lung Cancer
32%
Lung Tuberculosis
71%
Lymphocytopenia
9%
Methacholine
9%
Moxifloxacin
9%
Neopterin
9%
Non Small Cell Lung Cancer
43%
Observational Study
9%
Overall Survival
9%
Paclitaxel
9%
Pleura Effusion
9%
Prevalence
19%
Prospective Study
9%
Reflux Esophagitis
9%
Small Cell Lung Cancer
9%
Spontaneous Pneumothorax
9%
Syndrome
9%
Toll Like Receptor 2
9%
Topotecan
9%
Tuberculostatic Agent
11%
Nursing and Health Professions
Acute Cholecystitis
9%
Adult Respiratory Distress Syndrome
9%
Artificial Respiration
18%
Asthma
5%
Body Mass
19%
Clinical Feature
10%
Clinical Outcome
10%
Community Acquired Pneumonia
9%
Confidence Interval
51%
Elderly Patient
15%
Femur Fracture
9%
Fibrosing Alveolitis
9%
Forced Expiratory Volume
10%
Grip Strength
9%
Hazard Ratio
22%
Hospital Mortality
7%
Influenza A (H1N1)
9%
Intensive Care
5%
Long Term Care
9%
Lung Cancer
18%
Non Small Cell Lung Cancer
23%
Obstructive Lung Disease
23%
Odds Ratio
25%
Pandemic Influenza
9%
Prevalence
9%
Proportional Hazards Model
7%
Systolic Blood Pressure
9%
Tertiary Care Center
12%
Tidal Volume
9%